Capital International Sarl Eli Lilly & CO Transaction History

Capital International Sarl

$3.71 Billion
Q3 2024

A detailed history of Capital International Sarl transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital International Sarl holds 99,032 shares of LLY stock, worth $77.8 Million. This represents 2.36% of its overall portfolio holdings.

Number of Shares

99,032

Previous 87,348 13.38%

Holding current value

$77.8 Million

Previous $79.1 Million 10.94%

% of portfolio

2.36%

Previous 2.52%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $9.02 Million - $11.2 Million	11,684 Added 13.38%	99,032 $87.7 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $382,006 - $479,064	-527 Reduced 0.6%	87,348 $79.1 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $15.2 Million - $20.3 Million	-25,604 Reduced 22.56%	87,875 $68.4 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $5.35 Million - $6.31 Million	10,184 Added 9.86%	113,479 $66.1 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2.71 Million - $3.73 Million	6,231 Added 6.42%	103,295 $55.5 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $1.27 Million - $1.7 Million	3,618 Added 3.87%	97,064 $45.5 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $2.6 Million - $3.05 Million	-8,356 Reduced 8.21%	93,446 $32.1 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $3.66 Million - $4.27 Million	11,393 Added 12.6%	101,802 $37.2 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $314,861 - $358,817	1,062 Added 1.19%	90,409 $29.2 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $3.96 Million - $4.66 Million	14,225 Added 18.94%	89,347 $29 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $3.63 Million - $4.51 Million	15,477 Added 25.95%	75,122 $21.5 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $3.82 Million - $4.74 Million	16,993 Added 39.84%	59,645 $16.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $1.41 Million - $1.74 Million	-6,368 Reduced 12.99%	42,652 $9.86 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $95,510 - $123,542	529 Added 1.09%	49,020 $11.3 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $4.06 Million - $5.26 Million	24,714 Added 103.94%	48,491 $9.06 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $985,755 - $1.3 Million	-7,556 Reduced 24.12%	23,777 $4.02 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $1.14 Million - $1.32 Million	-7,818 Reduced 19.97%	31,333 $4.64 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $844,166 - $1.02 Million	6,188 Added 18.77%	39,151 $6.43 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $2.29 Million - $2.83 Million	19,221 Added 139.87%	32,963 $4.57 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $664,293 - $822,787	-6,213 Reduced 31.14%	13,742 $1.81 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.94 Million - $2.26 Million	-17,500 Reduced 46.72%	19,955 $2.21 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $1.84 Million - $2.16 Million	-16,500 Reduced 30.58%	37,455 $4.86 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $1.34 Million - $1.5 Million	12,655 Added 30.64%	53,955 $6.24 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $94,446 - $118,041	1,100 Added 2.74%	41,300 $0
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $267,156 - $315,360	-3,600 Reduced 8.22%	40,200 $3.11 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $354,800 - $380,563	4,330 Added 10.97%	43,800 $3.7 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.04 Million - $3.38 Million	39,470	39,470 $3.38 Million

Others Institutions Holding LLY

# of Institutions

4,033

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Account

Capital International Sarl Eli Lilly & CO Transaction History